Frank F. Sun
79 works · 4,378 citations · h-index 32
Top works
- The chemical structure of prostaglandin X (prostacyclin)
- The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
- Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization
- Calcium stimulation of a novel lipoxygenase
- Metabolism of prostaglandin F2α, in rhesus monkeys
- Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
- Metabolism of prostacyclin in rat
- Hepatic metabolism of prostacyclin (PGI2) in the rabbit: Formation of a potent novel inhibitor of platelet aggregation
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetase
- Prostaglandin 15-hydroxy dehydrogenase and Δ13 reductase levels in the lungs of maternal, fetal and neonatal rabbits
- Metabolism of prostaglandin F2α in the rat
- Metabolism of arachidonic acid by human neutrophils
- Leukotriene B4 biosynthesis by alveolar macrophages
- Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease
- 6-keto-prostaglandin E1 inhibits the aggregation of human platelets
- Reactive Oxygen Species Participate in Peroxynitrite-Induced Apoptosis in HL-60 Cells
- Abstract B232: Activity of a potent and selective phase I ALK inhibitor LDK378 in naive and crizotinib-resistant preclinical tumor models.
- NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R
- An evaluation of the relationship between arachidonic acid lipoxygenation and human neutrophil degranulation
- Effect of 6,9-deepoxy-6,9-(phenylimino)-Δ 6,8-prostaglandin 11 (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function